COMPOSITION PHARMACEUTIQUE DERMATOLOGIQUE DESTINÉE AU TRAITEMENT DE PATHOLOGIES INFLAMMATOIRES CUTANÉES TELLES QUE LA DERMATITE, LA DERMATITE ATOPIQUE, LE VITILIGO, L'ALOPÉCIE AREATA, L'ACNÉ, LE PSORIASIS ET LE PRURIT, ET DE COMBINAISONS DE CES DERNIÈRES
The invention relates to a dermatological pharmaceutical composition for the treatment of skin inflammation diseases, such as dermatitis, atopic dermatitis, vitiligo, alopecia areata, acne, psoriasis and pruritus. The invention comprises a base anti-inflammatory agent, such as indometacin； one or more optional active ingredients selected alternatively from among at least a corticoid and an antibiotic； and a combination of topical antioxidants used to potentiate the anti-inflammatory effect, selected from among green tea, lipoic acid, curcumin, ascorbyl palmitate, Coenzyme Q10, resveratrol, Pycnogenol TM , L-camosine, taurine, vitamin E, vitamin C, papaya extract, isoflavones, manganese, lycopene and quercetin. At least one of the topical antioxidants is a peroxisome proliferator-activated receptor-gamma (PPAR-³) activator. The invention also includes at least one antioxidant substance with an antiproliferative effect on keratonocytes, e.g. manganese, and at least one substance that blocks tumour necrosis factor-alpha (TNF-a) or other cytokines that provoke the acute phase of the inflammatory reaction, also with an antiproliferative effect, e.g. pentoxifylline.
